Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
88.50    -0.60 (-0.68%)
Bid:
88.00
Ask:
89.00
Spread: 1.00 (1.136%)
Market Cap: £59.03m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Director/PDMR Shareholding - Replacement

5 Apr 2018 12:02

The issuer advises that the following replaces the Eco Animal Health Group Plc 'Director/PDMR Shareholding' announcement released at 10:44 BST today.

In the third table, the 'Exercise' and 'Sale' figures in section 4b have been changed from 250,000 to 25,000.

All other details remain unchanged.

The full corrected version is shown below.

04 April 2018

ECO Animal Health Group plc ("ECO" or the "Company")

Director/PDMR Shareholding and Notification

1.   Details of the person discharging managerial responsibilities / person closely associated
a. Name   Marc Loomes
2. Reason for the notification
a. Position/status CEO
b. Initial notification

/Amendment

Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name ECO Animal Health Group plc
b. LEI 01818170
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each in the capital of the Company ( “Ordinary Shares” )

 

 

ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55

b. Nature of the transaction Exercise of 100,000 options over Ordinary Shares with an exercise price of £2.005

 

Sale of 100,000 Ordinary Shares at a price of £5.28

c. Price(s) and volume(s)

 

Price(s) Volume(s)

 

Exercise £2.005 100,000

 

Sale £5.28 100,000

 

d. Aggregated information

· Aggregated volume

· Price

As above

e. Date of the transaction 2018/04/04
f. Place of the transaction London Stock Exchange (XLON) AIM market
 
1. Details of the person discharging managerial responsibilities / person closely associated
a. Name   Kevin Stockdale
2. Reason for the notification
a. Position/status Finance Director
b. Initial notification

/Amendment

Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name ECO Animal Health Group plc
b. LEI 01818170
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each in the capital of the Company ( “Ordinary Shares” )

 

 

ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55

b. Nature of the transaction Exercise of 40,000 options over Ordinary Shares with an exercise price of £2.005

 

Sale of 40,000 Ordinary Shares at a price of £5.28

c. Price(s) and volume(s)

 

Price(s) Volume(s)

 

Exercise £2.005 40,000

 

Sale £5.28 40,000

 

d. Aggregated information

· Aggregated volume

· Price

As above

e. Date of the transaction 2018/04/04
f. Place of the transaction London Stock Exchange (XLON) AIM market
 
1. Details of the person discharging managerial responsibilities / person closely associated
a. Name   Andrew Buglass
2. Reason for the notification
a. Position/status PDMR
b. Initial notification

/Amendment

Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name ECO Animal Health Group plc
b. LEI 01818170
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each in the capital of the Company ( “Ordinary Shares” )

 

 

ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55

b. Nature of the transaction Exercise of 25,000 options over Ordinary Shares with an exercise price of £2.005

 

Sale of 25,000 Ordinary Shares at a price of £5.28

c. Price(s) and volume(s)

 

Price(s) Volume(s)

 

Exercise £2.005 25,000

 

Sale £5.28 25,000

 

d. Aggregated information

· Aggregated volume

· Price

As above

e. Date of the transaction 2018/04/04
f. Place of the transaction London Stock Exchange (XLON) AIM market
 
1. Details of the person discharging managerial responsibilities / person closely associated
a. Name   Marc Coulier
2. Reason for the notification
a. Position/status PDMR
b. Initial notification

/Amendment

Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a. Name ECO Animal Health Group plc
b. LEI 01818170
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a. Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 5p each in the capital of the Company ( “Ordinary Shares” )

 

 

ISIN: GB0032036807 LEI: 2138009XN9DJ3YP7OB55

b. Nature of the transaction Exercise of 20,000 options over Ordinary Shares with an exercise price of £2.005

 

Sale of 20,000 Ordinary Shares at a price of £5.28

c. Price(s) and volume(s)

 

Price(s) Volume(s)

 

Exercise £2.005 20,000

 

Sale £5.28 20,000

 

d. Aggregated information

· Aggregated volume

· Price

As above

e. Date of the transaction 2018/04/04
f. Place of the transaction London Stock Exchange (XLON) AIM market

Enquiries

ECO Animal Health Group plc

Marc Loomes, CEO 020 8447 8899

Peter Lawrence, Non -Executive Chairman 020 8336 6190

Spiro Financial

Anthony Spiro 020 8336 6196

N+1 Singer ( Nominated Adviser)

Mark Taylor, James White, Brough Ransom 020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel, Dr Christopher Golden 020 7418 8900

View source version on businesswire.com: https://www.businesswire.com/news/home/20180405005541/en/

Copyright Business Wire 2018

Date   Source Headline
25th Nov 20221:37 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSResults for the six months ended 30 September 2022
22nd Nov 20227:00 amRNSInvestor Presentation covering Interim Results
14th Nov 20227:00 amRNSChange of Auditor
31st Oct 20227:00 amRNSBlock listing Interim Review
24th Oct 20221:30 pmRNSHolding(s) in Company
24th Oct 20221:28 pmRNSHolding(s) in Company
26th Sep 20224:01 pmRNSResult of AGM
5th Sep 20221:00 pmRNSInvestor Presentation covering Full Year Results
2nd Sep 20227:00 amRNSPublication of Annual Report and Notice of AGM
31st Aug 20227:00 amRNSFinal Results for the Year Ended 31 March 2022
26th Aug 20221:13 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHolding(s) in Company
22nd Aug 20227:00 amRNSRevised Notice of Results
9th Aug 20227:00 amRNSDirectorate Change
8th Aug 202211:05 amRNSSecond Price Monitoring Extn
8th Aug 202211:00 amRNSPrice Monitoring Extension
8th Aug 20227:00 amRNSNotice of Results and Trading Update
11th Jul 20227:00 amRNSNew Banking Facility
6th Jul 20227:00 amRNSPartnership with Moredun Research Institute
15th Jun 20227:35 amRNSPartnership with Imperial College
12th May 202212:05 pmRNSDirector/PDMR Dealings
29th Apr 202211:47 amRNSBlock Listing Interim Review
1st Apr 20227:00 amRNSDirector/PDMR Dealings
30th Mar 20227:00 amRNSDirector/PDMR Dealings
23rd Mar 20225:53 pmRNSDirector/PDMR Dealing
21st Mar 20227:00 amRNSDirector/PDMR Dealing
15th Mar 20227:00 amRNSPre-close Trading Update
23rd Feb 20227:00 amRNSNew Marketing Authorisations for Aivlosin in China
1st Feb 20221:53 pmRNSHolding(s) in Company
24th Jan 20227:00 amRNSInvestor Presentation
18th Jan 20227:01 amRNSHolding(s) in Company
18th Jan 20227:00 amRNSChief Executive Officer Appointment
13th Jan 20229:29 amRNSHolding(s) in Company
12th Jan 20227:00 amRNSTrading update, Appointment of Joint Broker & CMD
6th Dec 20218:14 amRNSHolding(s) in Company
1st Dec 20217:00 amRNSBoard Appointment
30th Nov 202112:39 pmRNSDirector Dealings
25th Nov 20217:00 amRNSResults for the six months ended 30 September 2021
23rd Nov 20217:00 amRNSInvestor Presentation covering Interim Results
1st Oct 20218:47 amRNSTotal Voting Rights & Share Capital
27th Sep 202112:06 pmRNSDeferred Share Awards to Executive Directors
17th Sep 20217:00 amRNSResult of AGM
16th Sep 20217:00 amRNSAGM Statement
19th Aug 20217:00 amRNSPublication of Annual Report and Notice of AGM
12th Aug 20218:30 amRNSHolding(s) in Company
28th Jul 20212:40 pmRNSDirectors Dealings
26th Jul 20217:00 amRNSBoard Changes
26th Jul 20217:00 amRNSFinal Results for Year Ended 31 March 2021
28th May 20212:31 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.